Related Experiment Video
Updated: Aug 13, 2026

Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
Transforming growth factor-alpha and beta-amyloid precursor protein share a secretory mechanism
1Cell Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York 10021.
Abstract:
Cleavage and release of membrane protein ectodomains, a regulated process that affects many cell surface proteins, remains largely uncharacterized. To investigate whether cell surface proteins are cleaved through a shared mechanism or through multiple independent mechanisms, we mutagenized Chinese hamster ovary (CHO) cells and selected clones that were unable to cleave membrane-anchored transforming growth factor alpha (TGF-alpha). The defect in TGF-alpha cleavage in these clones is most apparent upon cell treatment with the protein kinase C (PKC) activator PMA, which stimulates TGF-alpha cleavage in wild-type cells. The mutant clones do not have defects in TFG-alpha expression, transport to the cell surface or turnover. Concomitant with the loss of TGF-alpha cleavage, these clones have lost the ability to cleave many structurally unrelated membrane proteins in response to PMA. These proteins include beta-amyloid precursor protein (beta-APP), whose cleavage into a secreted form avoids conversion into the amyloidogenic peptide A beta, and a group of cell surface proteins whose release into the medium is stimulated by PMA in wild type CHO cells but not in mutants. The mutations prevent cleavage by PKC-dependent as well as PKC-independent mechanisms, and thus affect an essential component that functions downstream of these various signaling mechanisms. We propose that regulated cleavage and secretion of membrane protein ectodomains is mediated by a common system whose components respond to multiple activators and act on susceptible proteins of diverse structure and function.
Insights
Researchers identified a common system responsible for cleaving and releasing membrane protein ectodomains. This system is crucial for processing various cell surface proteins, including transforming growth factor alpha (TGF-alpha) and beta-amyloid precursor protein (beta-APP).
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Regulated cleavage and release of membrane protein ectodomains are critical cellular processes affecting numerous cell surface proteins.
- The precise mechanisms governing this ectodomain shedding remain largely uncharacterized, with questions about shared versus independent pathways.
Purpose of the Study:
- To investigate whether cell surface proteins are cleaved via a common mechanism or multiple independent pathways.
- To identify the components involved in the regulated cleavage of membrane protein ectodomains.
Main Methods:
- Mutagenesis of Chinese hamster ovary (CHO) cells to select clones with defects in membrane protein ectodomain cleavage.
- Treatment of wild-type and mutant CHO cells with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA).
- Analysis of cleavage defects in transforming growth factor alpha (TGF-alpha), beta-amyloid precursor protein (beta-APP), and other PMA-stimulated cell surface proteins.
Main Results:
- Mutant CHO clones were identified that were unable to cleave TGF-alpha, even upon PMA stimulation.
- These mutant clones also exhibited a loss of ability to cleave structurally unrelated membrane proteins, including beta-APP and other PMA-inducible cell surface proteins.
- The observed defects were independent of protein expression, cell surface transport, or turnover, and affected both PKC-dependent and PKC-independent cleavage mechanisms.
Conclusions:
- A common system mediates the regulated cleavage and secretion of membrane protein ectodomains.
- This system's components respond to multiple activators and act on diverse protein substrates.
- The findings suggest a unified mechanism for ectodomain shedding, impacting various cell signaling pathways.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Protein Folding Quality Check in the RER
Insulin Secretory Vesicles
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
TGF - β Signaling Pathway

